Literature DB >> 12686869

Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract.

Christopher P Smith1, Michael E Franks, Brian K McNeil, Rudrani Ghosh, William C de Groat, Michael B Chancellor, George T Somogyi.   

Abstract

PURPOSE: The magnitude and duration of the effects of botulinum toxin A on acetylcholine (ACh) and norepinephrine release from the bladder and urethra of rats were measured using a radiochemical method.
MATERIALS AND METHODS: Saline (sham treatment) or botulinum toxin A was injected into the bladder (50 microl.) or urethra (30 microl.) in separate groups of animals. The release of 3H-norepinephrine or 14C-choline was measured at 2 time points after injection (5 or 30 days).
RESULTS: The fractional release of ACh in botulinum toxin A treated animals was significantly inhibited at higher frequencies of electrical field stimulation (20 Hz.) but not at lower frequencies (2 Hz.) 5 days after injection. However, ACh release recovered to sham injected values 30 days after toxin injection. No significant differences in the fractional release of norepinephrine from sham injected or botulinum toxin A bladders were observed. In contrast, norepinephrine release from the urethra was inhibited by botulinum toxin A for at least 30 days after injection. Similar to its effect on transmitter release in the bladder, botulinum toxin A inhibited norepinephrine release in the urethra at high (20 Hz.) but not at low (4 Hz.) electrical stimulation frequencies.
CONCLUSIONS: These data indicate that the clinical effects of botulinum toxin A on the lower urinary tract may vary depending on the site of injection and level of nerve activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12686869     DOI: 10.1097/01.ju.0000049202.56189.54

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  38 in total

Review 1.  Alternative approaches to sacral nerve stimulation.

Authors:  Kenneth M Peters
Journal:  Int Urogynecol J       Date:  2010-12       Impact factor: 2.894

Review 2.  Botulinum A toxin for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms.

Authors:  Catherine A Thomas; Yao-Chi Chuang; Antonella Giannantoni; Michael B Chancellor
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

Review 3.  [Botulinum toxin for the treatment of neurogenic detrusor hyperactivity. Consensus paper on use for neurogenic bladder dysfunction].

Authors:  K-D Sievert; J Bremer; H Burgdörfer; B Domurath; C Hampel; J Kutzenberger; C Seif; M Stöhrer; B Wefer; J Pannek
Journal:  Urologe A       Date:  2007-03       Impact factor: 0.639

Review 4.  Integrative control of the lower urinary tract: preclinical perspective.

Authors:  William C de Groat
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

5.  Can the ice-water test predict the outcome of intradetrusor injections of botulinum toxin in patients with neurogenic bladder dysfunction?

Authors:  Mirjam Huwyler; Brigitte Schurch; Peter A Knapp; André Reitz
Journal:  World J Urol       Date:  2007-08-13       Impact factor: 4.226

6.  Characterizing the Bladder's Response to Onabotulinum Toxin Type A Using a Rat Model.

Authors:  Alexis A Dieter; Jennifer M Wu; Nazema Y Siddiqui; Danielle J Degoski; Jillene M Brooks; Paul C Dolber; Matthew O Fraser
Journal:  Female Pelvic Med Reconstr Surg       Date:  2016 Nov/Dec       Impact factor: 2.091

Review 7.  Ten years single surgeon experience with botulinum toxin in the urinary tract; clinical observations and research discovery.

Authors:  Michael B Chancellor
Journal:  Int Urol Nephrol       Date:  2009-07-02       Impact factor: 2.370

Review 8.  A review of botulinum toxin use for chronic pelvic pain syndrome.

Authors:  Henry P Gottsch; Claire C Yang; Richard E Berger
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

Review 9.  Neural control of lower urinary tract and targets for pharmacological therapy.

Authors:  Maria Augusta T Bortolini; Andreisa P M Bilhar; Rodrigo A Castro
Journal:  Int Urogynecol J       Date:  2014-07-08       Impact factor: 2.894

Review 10.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.